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A novel lesion-mask free method based on a gamma mixture model was applied
to myelin water fraction (MWF) maps to estimate the association between cortical
thickness and myelin content, and how it differs between relapsing-remitting (RRMS)
and secondary-progressive multiple sclerosis (SPMS) groups (135 and 23 patients,
respectively). It was compared to an approach based on lesion masks. The gamma
mixture distribution of whole brain, white matter (WM) MWF was characterized with three
variables: the mode (most frequent value) m1 of the gamma component shown to relate
to lesion, the mode m2 of the component shown to be associated with normal appearing
(NA) WM, and the mixing ratio (λ) between the two distributions. The lesion-mask
approach relied on the mean MWF within lesion and within NAWM. A multivariate
regression analysis was carried out to find the best predictors of cortical thickness
for each group and for each approach. The gamma-mixture method was shown to
outperform the lesion-mask approach in terms of adjusted R2 , both for the RRMS and
SPMS groups. The predictors of the final gamma-mixture models were found to be m1
(β = 1.56, p < 0.005), λ (β = −0.30, p < 0.0005) and age (β = −0.0031, p < 0.005)
for the RRMS group (adjusted R2 = 0.16), and m2 (β = 4.72, p < 0.0005) for the SPMS
group (adjusted R2 = 0.45). Further, a DICE coefficient analysis demonstrated that the
lesion mask had more overlap to an ROI associated with m1 , than to an ROI associated
with m2 (p < 0.00001), and vice versa for the NAWM mask (p < 0.00001). These
results suggest that during the relapsing phase, focal WM damage is associated with
cortical thinning, yet in SPMS patients, global WM deterioration has a much stronger
influence on secondary degeneration. Through these findings, we demonstrate the
potential contribution of myelin loss on neuronal degeneration at different disease stages
and the usefulness of our statistical reduction technique which is not affected by the
typical bias associated with approaches based on lesion masks.
Keywords: multiple sclerosis, cortical thickness, white matter, myelin water fraction, RRMS, SPMS
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1. INTRODUCTION

same variability between themselves as between experimenters
manually drawing or editing masks.
The aim of this work was 2-fold. First, to evaluate
the association between cortical thickness and WM myelin,
quantified from the measured MWF distribution in whole brain
WM, and assess if this relationship differed between disease
stages, that is between RRMS and SPMS patients. Second, to
propose for the first time a model of the distribution of cerebral
white matter MWF with a statistical reduction technique which
circumvents the bias introduced by the use of lesion masks.

The mechanisms of cortical atrophy in multiple sclerosis (MS)
are poorly understood. MS is typically characterized by the
appearance of white matter (WM) lesions on T2 FLAIR magnetic
resonance imaging (MRI) images. Although lesions are the most
visible radiological aspect of the disease, used for both diagnosis
(Polman et al., 2011) and clinical trials (Polman et al., 2006;
Kappos et al., 2007; Mikol et al., 2008), disability has been shown
to have a stronger correlation with gray matter (GM) cortical
atrophy compared to WM measurements (Ramasamy et al., 2009;
Calabrese et al., 2010, 2011; Narayana et al., 2013). It is then
of particular interest to explore the mechanisms driving cortical
thinning.
Wallerian degeneration as a result of chronic demyelination
has been implicated as one potential mechanism for cortical
GM loss (Peterson et al., 2001; Vercellino et al., 2005; Geurts
and Barkhof, 2008), however the extent that demyelination
contributes to this process has yet to be fully elucidated.
Interestingly, it has been shown that the rate of GM atrophy
is markedly different between the remitting relapsing (RR) and
secondary progressive (SP) phases of the disease (Fisher et al.,
2008). Therefore, we hypothesize that the relationship between
WM demyelination and cortical thinning is different among
these two disease stages.
Quantifying WM demyelination, especially myelin loss has
been challenging, and several MRI sequences have been utilized
to obtain an imaging biomarker of myelin integrity in MS,
including diffusion MRI (Rovaris et al., 2005), magnetization
transfer ratio (MTR) imaging (Horsfield, 2005) and myelin
water fraction (MWF) imaging (Laule et al., 2004). Although
promising, the clinical utility of MWF maps has been impeded
by a prohibitively long acquisition time of the associated T2
relaxometry MRI sequence and challenging T2 data analysis
(Kolind et al., 2009). To improve the efficiency of T2 data
acquisition, we optimized a 3D T2prep GRE sequence (Nguyen
et al., 2012), which is able to achieve full brain coverage within
10 min at 3T and feasible to integrate into a clinical imaging
protocol.
WM damage is traditionally quantified globally from the
“lesion load”: the total volume of visible lesions on a dedicated
MRI sequence such as FLAIR. This approach has limitations as
the normal-appearing (NA) WM was shown to have pathological
changes (Evangelou et al., 2000), and similarly for “dirty WM”
(Seewann et al., 2009) which includes voxels with intermediate
intensity between lesion and NAWM. Additionally, while
advanced MRI sequences provide metrics to quantify local WM
damage, they still rely on the creation of associated lesion masks.
These suffer from two main issues: there is inter-rater variability
in their drawing or editing, and they are time-consumming to
create, thus not adapted to large cohorts (Egger et al., 2017).
Automated methods for mask generation alleviate somewhat
both these issues, via high reproducibility and fast computer
automation, respectively. However the associated algorithms are
often calibrated to generate an output in agreement with a given
experimenter and therefore are inherently biased. As a result,
automated methods of lesion mask creation have around the
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2. MATERIALS AND METHODS
2.1. Subjects
Patient clinical and MRI data utilized for this analysis was part
of a larger MRI and clinical database collection study at the
Judith Jaffe Multiple Sclerosis Center, Weill Cornell Medicine,
Department of Neurology, New York, USA. The MS database
study was approved by Weill Cornell Medicine institutional
review board and all subjects were consented for participation
during their routine clinical visits. Informed and written consent
for data collection and publication was obtained from study
participants.
One-hundred and fifty-seven patients with the diagnosis of
multiple sclerosis (Polman et al., 2005), including RRMS and
SPMS were selected from our database. Patients were selected
from our ongoing data collection, and informed consent was
obtained from each subject. All RRMS and SPMS patients with
a clinical MRI sequence that included the T2prep 3D spiral
sequence were included in the analysis. Patient characteristics
(Table 1) and clinical data were obtained within 3 months of the
individual’s brain MRI. The following clinical data was collected:
gender, age, disease duration (DD) from initial symptom,
Expanded Disability Status Score (EDSS), disease subtype, and
duration of treatment with disease modifying therapy (DMT).

2.2. MRI Data Acquisition
Each participant underwent T1, FLAIR, and T2 relaxometry
sequences with a 3Tesla GE scanner (HDxt 16.0) using 8-channel

TABLE 1 | RRMS and SPMS group demographics and disease
characteristics.
Characteristics

SPMS

Welch two
sample t-test

Patients, n

134

23

N/A

Females

90

16

N/A

Disease duration,
mean ± SD

7.7 years ± 7.3

21.7 years ± 11.0

p < 0.00001

Treatment Duration,
mean ± SD

4.2 years ± 4.1

10.6 years ± 6.1

p < 0.00001

Age, mean ±SD

2

RRMS

40.3 ± 9.7

57.4 ± 7.8

p < 0.00001

Cortical thickness,
mean ± SD

2.46 mm ± 0.13

2.27 mm ± 0.17

p < 0.00001

Whole-brain WM
MWF, mean ± SD

0.1388 ± 0.0205

0.1173 ± 0.0206

p < 0.0001
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phased-array coil. The T1 sequence was an axial 3D inversion
recovery fast spoiled gradient recalled echo (FSPGR) resulting
in T1 volumes with 1.2 mm isotropic resolution. The T2 FLAIR
volumes had 1.2 × 0.6 × 0.6 mm3 resolution. The T2 relaxometry
sequence was a whole-brain T2prep 3D spiral as previously
described by Nguyen et al. (2012) and included the following
parameters: axial FOV = 24 cm; matrix size = 192 × 192
(interpolated to 256 × 256); slice thickness = 5 mm; number
of slices = 32; sequence TR (time between subsequent T2prep
pulses) = 2.5 s; spiral TR = 8.1 milliseconds (ms); spiral TE = 0.5
ms; flip angle = 10◦ ; readout bandwidth = ±125 kHz; number
of spiral leaves per segment = 64; 15 nominal T2prep times = 0,
5 ms, 10–40 ms (10 ms step), 60–140 ms (20 ms step), 180–300
ms (40 ms step); scan time = 10 min. A modified BIR-4 adiabatic
pulse (De Graaf and Nicolay, 1998; Jenista et al., 2013) was used
in the T2prep module to improve T2 weighting accuracy against
increased B0 and B1 field inhomogeneities at 3T.

2.3. T2 Relaxometry Post-processing
Recently, we reported a multi-voxel spatial regularization
approach to analyze multiexponential T2 decay data, with
the goal of obtaining usable myelin maps from noisy but
fast acquisitions (Kumar et al., 2012). The size and stability
of the challenging minimization problem has been greatly
reduced by our subsequent fitting method, called “Spatially
constrained multi-Gaussian” algorithm, described in Raj et al.
(2014). Briefly, it employs a non-linear model to recognize
only three distinct water compartments contributing to the T2
spectrum, s, in each voxel: myelin water modeled by a gaussian
G(µMW , σMW ), intra/extra-cellular water modeld by another
gaussian G(µCW , σCW ) and cerebral spinal fluid modeled by a
delta function δ(µCSF ). In each voxel, s is then given by a linear
combination of these contributions: s = cMW G(µMW , σMW ) +
cCW G(µCW , σCW ) + cCSF δ(µCSF ). The MWF is defined as
the ratio between the portion of the signal coming from
myelin water, and the total signal from all water compartments:
MWF = cMW +ccMW
. The resultant MWF maps were shown to
CW +cCSF
provide good spatial resolution and visual lesion discrimination
(Figure 1). Note that the lesion-mask free method presented in
this work and described in Section 2.6 does not depend on the
method used to compute MWF.

FIGURE 1 | Examples of T2 FLAIR images (left) from two MS patients
(A,B) and corresponding MWF maps (right) demonstrate good spatial
resolution and sensitivity to visually T2 hyperintense lesions. The color bar
represents the range of MWF values. Hyperintense lesions on T2 Flair images
are found to have low MWF values as compared to the surrounding NAWM.
MWF also appears sensitive to dirty WM, as shown by the low MWF displayed
in dark/light blue within the central white matter of (B).

was linearly coregistered to the subjects T1 with FSL (http://fsl.
fmrib.ox.ac.uk/fsl/fslwiki). The inverse of this transform was then
applied to the WM mask to get it into the same space as the MWF
maps.

2.5. FLAIR Post-processing and Lesion
Masks
The white matter hyperintensity lesion masks were created from
the T2 FLAIR images aligned onto FreeSurfer volume with
the boundary-based registration (Greve and Fischl, 2009). The
skullstripped FLAIR images were bias-corrected and segmented
in three tissue classes with FSL FAST (Zhang et al., 2001) based
on the image intensities. The third tissue class included both CSF
tissue and WM lesions. Only voxels of the the bias-corrected
FLAIR image belonging to that class and to the Freesurfer
WM mask were kept as WM lesion candidate voxels. The
associated volume was further thresholded to select only voxels
with intensity greater than the 30th percentile of the FSL “robust
intensity range” defined as the range of intensities between the
2nd and 98th percentile. The thresholded maps were finally
binarized to provide the lesion masks.
The resulting WM lesion masks were overlaid on FLAIR
images and manually edited to ensure an optimal match with the
lesion hyper-intensities seen on the underlaid FLAIR contrast.
A trained neurologist gave a final approval on these edits.
The NAWM masks were defined as the voxels of the WM
mask not belonging to the WM lesion mask. As a result
the lesion and NAWM masks were mutually exclusive. The

2.4. T1 Post-processing and Cortical
Thickness
FreeSurfer (http://freesurfer.net) was used to segment T1
images into GM and WM masks, which were visually checked
and manually edited for misclassification due to WM T1hypointensities associated with lesions. This editing was limited
to ensuring that no WM was included in the GM mask. It was
different from the lesion-mask editing procedure detailed in the
next section (and applied to FLAIR contrast) which involved
separating NAWM from every single lesion present within the
global WM mask.
After completion, a trained neurologist (SG) gave a final
approval on the resulting GM and WM masks. Cortical thickness
measurements were then directly obtained with FreeSurfer from
the corrected masks. The 1st echo of the T2 relaxometry sequence
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(1−λi )Ŵ(MWF; α2,i , β2,i ) where Ŵ denotes a gamma distribution,
λi is the proportion of mixing between the two distributions,
and the “shape” and “scale” pairs (α1,i , β1,i ) and (α2,i , β2,i ) are
the parameters describing the shape and scale of each mixture
component (Figure 2). In contrast, using simply the mean MWF
would have lost the information contained in this distribution,
especially the presence of two peaks.
The shape parameter controls the skewness of the distribution
while the scale controls how spread the distribution is. The
position of the peak in each component of the distribution,
i.e., the distribution modes, are given by m1 = (α1 − 1) ×
β1 and m2 = (α2 − 1) × β2 . Another reason we chose the
gamma distribution as opposed to another one, is that the
parameters are easier to interpret, and directly relate to explicit
quantities such as the mean and modes of the distribution as just
described. For the single gamma distribution, parameters were
estimated with the maximum-likelihood (ML) method, while for
the gamma mixture distribution they were estimated with the
expectation maximization (EM) method (Dempster et al., 1977).
A penalized likelihood ratio test was implemented to determine
the goodness of fit of the mixture gamma compared to the
single gamma model (Wong and Li, 2014) and choose between
the two.

transform obtained described in the T1 post-processing section
was used to obtain the lesion and NAWM masks in MWF
space.

2.6. MWF Distribution
We analyzed MWF maps within WM masks for each patient
using plots and descriptive statistics. The observed distributions
of MWF values (at the patient level) appeared skewed and with
one or two prominent peaks (Figures 2, 3). One of the most
common skewed distribution is the gamma distribution, used
in fields ranging from economics (Chatterjee and Chakrabarti,
2007; Chotikapanich and Griffiths, 2008) to meteorology (Smith,
2003; Yoo et al., 2005) as either a single distribution (Smith, 2003;
Chatterjee and Chakrabarti, 2007) or mixture of two distributions
(Yoo et al., 2005; Chotikapanich and Griffiths, 2008). The skewed
distribution of our data also presented one or two peaks and
exploratory analysis demonstrated a tight visual fit from a
gamma model. These elements provided ground for describing
the data distributions as either a gamma random variable
or a mixture of two gamma-distributed random variables. In
other words, we hypothesized that for each patient i, the
MWF distribution pi (MWF) followed a mixture of two gamma
distributions of the form pi (MWF) = λi Ŵ(MWF; α1,i , β1,i ) +

FIGURE 2 | Illustration of the same gamma mixture distribution with two different values of λ. m1 and m2 are the modes (most frequent values) of the low
and high MWF components of the gamma mixture, respectively. λ is the gamma mixture mixing ratio and represents the proportion of low MWF to high MWF (when λ
is equal to 0.5, the two components have the same contribution in the gamma mixture). To compare the relationship between lesion/NAWM masks and each gamma
mixture component we defined ROI[m1 ] and ROI[m2 ] as all voxels with MWF value less than m1 (in red) and greater than m2 (in green), respectively. We assumed the
lesion mask had more overlap with ROI[m1 ] than ROI[m2 ], and the NAWM mask more overlap with ROI[m2 ] than ROI[m1 ]. (Left) Distribution with a λ value less than
0.5 (exact parameters: m1 = 0.06, m2 = 0.17, λ = 0.25). (Right) Distribution with a λ value greater than 0.5 (exact parameters: m1 = 0.06, m2 = 0.17, λ = 0.75).
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FIGURE 3 | Gamma mixture fits of 3 RRMS subjects (left column) and 3 SPMS subjects (right column). Histograms are only represented for illustrative
purposes and were not used during the fitting procedure.
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2.7. Interpretation of the Gamma Mixture
Parameters in Terms of Lesion and NAWM

Computing, R Development Core Team, Vienna, Austria, 2011,
http://www.R-project.org.

Our assumption was that the lesion mask was more associated
to the low-MWF component at position m1 , compared to the
high-MWF component at position m2 . Similarly, we expected
the NAWM mask to be more associated to the high-MWF
component than to the low-MWF component. To test the
first assumption, we computed a metric of similarity between
the lesion mask and a region of interest ROI[m1 ] associated
with the low-MWF component at m1 , and between the lesion
mask and a region ROI[m2 ] associated with the high-MWF
component at m2 . We then tested if the metric of similarity
was significantly higher between the lesion mask and ROI[m1 ]
than between the lesion mask and ROI[m2 ]. The metric of
similarity was chosen to be the Dice coefficient, commonly
use in neuroimaging to compute the overlap of two ROIs (see
e.g., Dayan et al., 2015). It is defined for two regions A and
B as Dice(A, B) = 2×|A∩B|
|A|+|B| where |X| stands for the number
of voxels in region X. ROI[m1 ] was defined as the region
with voxels having MWF value below m1 , and ROI[m2 ] was
defined as the region with voxels having MWF value above m2
(Figure 2). We therefore tested if Dice(lesion mask, ROI[m1 ]) >
Dice(lesion mask, ROI[m2 ]), using a Welch two sample t-test.
Similarly, to test our second assumption that the NAWM mask
is more associated to the high-MWF component than to the lowMWF component, we used a Welch two sample t-test to test that
Dice(NAWM mask, ROI[m2 ]) > Dice(NAWM mask, ROI[m1 ]).

3. RESULTS
3.1. Multiple Metrics Measured in a Large
Cohort of RRMS and SPMS Patients
In all patients, the T2 spiral sequence was easily placed within
the clinical protocol given the feasible acquisition time of only
10 min. The combination of T2 spiral acquisition and multiGaussian post-processing algorithm produced whole brain, highresolution MWF white matter maps with good lesion detection
(Figure 1).
Cortical thickness measures and other patient characteristics
in each of the RRMS and SPMS groups are summarized
in Table 1. Univariate t-tests (Welch Two Sample t-tests)
demonstrated significant differences in age, cortical thickness and
mean whole-brain WM MWF between the RRMS and SPMS
groups.

3.2. Modeling Whole Brain White Matter
MWF Distribution
Lesion centric data analysis based upon semi-automated lesion
mapping programs introduces a bias based upon the reviewer’s
determination of perceived regions of pathology. We know that
regions considered to be dirty WM on T2 imaging have less
myelin (Moore et al., 2008; Seewann et al., 2009), therefore we
considered an unbiased approach to model each individual’s
whole brain white matter MWF data as either a gamma
random variable or a mixture of two gamma-distributed random
variables. The likelihood ratio test provided p-values less than
0.00001 in all patients, thus there was statistical evidence to
conclude that a gamma mixture distribution was preferred over
the single gamma distribution. As a result the gamma mixture
model was chosen for all patients. Further, a univariate t-test
demonstrated a significant difference in mean whole-brain WM
MWF between the RRMS and SPMS groups (Table 1), suggesting
a possible differential distribution of MWF in each of these
groups. Figure 3 includes examples of 6 individual patients;
the figure shows a histogram of the MWF raw data and the
smooth green curve represents the fitted mixture distribution.
Different distribution shapes according to MS groups are visible
on that figure, with a trend to higher m1 and m2 , and lower
λ, in RRMS patients compared to SPMS patients. Note that the
method used to carry out the gamma mixture fitting, expectation
maximization, did not rely on the binning of the data or its
representation as an histogram. Histograms have been created
exclusively for visualization of the fitting procedure outcome.

2.8. Group Analysis
To assess the association between the distribution of MWF for
our cohort of MS patients and cortical thickness, we used a
multivariate linear regression model. In order to compare our
statistical reduction technique with a classical method based on
lesion masks, we used two sets of possible predictors. For our
gamma-mixture approach we considered as predictor variables
the MWF distribution mixing factor λ, and distribution modes
m1 and m2 . For the standard approach based on lesion masks,
we used mean MWF in the lesion mask validated by the trained
neurologist, and mean MWF in the mutually exclusive NAWM
mask. We also considered for both sets of predictors age, gender,
DMT and DD. The best model for each approach and each group
was chosen according to the procedure detailed in the Appendix.
One aim was to compare the best model obtained with
predictors derived from our statistical reduction method and the
best model obtained with predictors derived from the classical
approach based on lesion masks. This was carried out in each
group by comparing the adjusted R2 of these two models.
Another aim was to examine if the final models were different in
the RRMS and SPMS group, and interpret the models in terms
of their predictors. To help in this endeavor, we assessed the
contribution of each coefficient to R2 by calculating the average
contribution of that coefficient when added to all possible models
excluding that coefficient, as in Lindeman et al. (1980).
All p-values were two-sided with statistical significance
evaluated at the 0.05 alpha level. Statistical analysis was
conducted using R: A Language and Environment for Statistical
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3.3. Relationship between Gamma Mixture
Components and Lesion/NAWM Masks
To interpret the gamma-mixture model parameters in terms
of the underlying pathology, we tested that the lesion mask
had a higher Dice coefficient with ROI[m1 ], defined from the
first gamma component, than with ROI[m2 ], defined from the
second component, in both RRMS and SPMS groups. The t-test
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3.4. Predictors of Cortical Thickness for
SPMS and RRMS Patients

demonstrated it was significantly higher in each group (p <
0.00001, Figure 4, top).
Similarly we tested that the NAWM had a higher Dice
coefficient with ROI[m2 ] than with ROI[m1 ] in both groups, and
it was also significantly higher in each group (p < 0.00001,
Figure 4, bottom).
This provided support for interpretating m1 as associated to
lesioned WM and m2 to NAWM. An illustration of lesion and
NAWM masks, as well as ROI[m1 ] and ROI[m2 ], is provided in
Figure 5. It can be seen that ROI[m1 ] tend to overlap with the
lesion mask while also including dirty WM, while ROI[m2 ] is
mostly included within NAWM and tend to exclude lesion and
dirty WM.

We reasoned that the degree of cortical atrophy may directly
correlate with whole brain myelin content. More precisely,
we wanted to test the hypothesis that MWF distribution
was associated with cortical thickness, and that a differential
association existed between MS groups. We also investigated how
a fully automated model performed to accomplish this objective
compared to a classical approach based on manually edited lesion
masks.
For the gamma-mixture approach, we utilized three
metrics from the MWF distribution (λ, m1 , m2 ) to explore
the relationship of myelin and cortical thickness among RRMS

FIGURE 4 | Comparison of dice coefficient between ROIs from gamma mixture components and lesion/NAWM masks in (left) RRMS and (right) SPMS
groups. (Top) Comparison between lesion mask and ROI[m1 ], and lesion mask and ROI[m2 ] in (left) RRMS and (right) SPMS groups. The difference was shown to be
significant in both RRMS (p < 0.00001) and SPMS (p < 0.00001) groups. (Bottom) Comparison between NAWM mask and ROI[m1 ], and NAWM mask and ROI[m2 ]
in (left) RRMS and (right) SPMS groups. The difference was shown to be significant in both RRMS (p < 0.00001) and SPMS (p < 0.00001) groups. *p < 0.01,
**p < 0.001, ***p < 0.0001, ****p < 0.00001.
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FIGURE 6 | Relative contribution to total R2 of the cortical thickness
regression coefficients for the RRMS group.

adjusted R2 for the gamma-mixture approach demonstrated
that the automated method outperformed the lesion mask
approach to explain the variance in cortical thickness in
either patient group. Further, comparing the final models
in each approach, {mean NAWM MWF} and {m2 } for the
SPMS group, and {age, mean lesion MWF} and {λ, m1 , age}
for the RRMS group, brought additional evidence of the
surrogate relationship between NAWM and the second gammamixture component, and lesion and the first gamma-mixture
component.
Analyzing in more details the statistical reduction model,
we found that for the RRMS group, the regression coefficients
of the predictor variables were −0.0031 (p < 0.005) for age
(in years), 1.56 (p < 0.005) for m1 (in MWF, a ratio) and
−0.30 (p < 0.0005) for λ (a ratio). One can interpret these
coefficients as showing that on average a cortical thickness
decrease of 0.05 mm is associated with an age increase of 16
years (all other variables held constant), an m1 decrease of 0.032
(all other variables held constant) or a λ increase of 0.17 (all
other variables held constant). As a reminder, m1 and m2 are the
two modes of the gamma mixture distribution, corresponding
to the low and high MWF components of the distribution,
determined to relate to lesion and NAWM, respectively, while
λ is the mixing ratio determining the proportion of each
component in the mixture. A high λ represents a higher
contribution of low WM MWF to the gamma mixture while
a low λ represents a higher contribution of high WM MWF
(Figure 2).
The contribution of each coefficient to the absolute R2
is shown in Figure 6. It can be seen that in decreasing
order (in terms of contribution to R2 ) the coefficients are

FIGURE 5 | Illustration of lesion and NAWM masks, and their
relationships with the ROIs defined from the gamma mixture, ROI[m1 ]
and ROI[m2 ], in one (A) RRMS and one (B) SPMS patients. (Top) FLAIR
images with hyperintensities corresponding to lesions. (Middle) Lesion mask
(red) and ROI[m1 ] (blue). (Bottom) NAWM mask (green) and ROI[m2 ] (yellow).
ROI[m1 ] and ROI[m2 ] have been created from the gamma mixture so that not
to overlap one with the other (cf. Figure 2), and as a result they only represent
part (approximately half) of each gamma component. Despite this limitation, it
can be clearly seen that the lesion mask is more similar to ROI[m1 ] than to
ROI[m2 ], and that the NAWM mask is more similar to ROI[m2 ] than to ROI[m1 ],
as corroborated by the DICE coefficient calculations shown in Figure 4.

and SPMS patients. For the standard approach we used the mean
MWF in the lesion mask and the mean MWF in the NAWM
mask. In both cases we controlled for other demographics and
patient predictors, (age, gender, DD, DMT) and applied an
exhaustive model search coupled to 10-fold cross-validation to
select the best model for each approach and for each RRMS
and SPMS group (cf. Appendix). For the classical approach,
the final parameters kept in the model were {age, mean lesion
MWF} with a resulting adjusted R2 of 0.13 for the RRMS
group, and were solely {mean NAWM MWF} with a resulting
adjusted R2 of 0.39 for the SPMS group. For the statistical
reduction approach, the final parameters were {λ, m1 , age} with
an adjusted R2 of 0.16 for the RRMS group, and were {m2 }
with an adjusted R2 of 0.45 for the SPMS group. The greater
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4.1. Gamma-Mixture Fitting Applied to
MWF

λ, age and m1 , all having a relative importance greater
than 20%.
For the SPMS group, the regression coefficient was 4.72
(p < 0.0005) for m2 , i.e., on average, a cortical thickness
decrease of 0.05 mm is associated with an m2 decrease of 0.011.
The association between cortical thickness and the position
of the gamma mixture second mode m2 is illustrated in
Figure 7.
These results suggest a marked difference in the association
between cortical thickness and WM MWF distribution in RRMS
and SPMS patients.

Multi-component T2 relaxometry (Koenig et al., 1990; MacKay
et al., 1994, 2006; Whittall et al., 1997; Laule et al., 2004, 2007)
is a promising noninvasive method to measure MWF. MWF
has been shown to correlate highly with histological myelin
measurement in rodents (Gareau et al., 2000; Kozlowski et al.,
2008; McCreary et al., 2009) and myelin content in post-mortem
MS samples, (Moore et al., 2000, 2008; Laule et al., 2006,
2008, 2011) but there have been limited studies translating this
technique to study the association with MS disease variables.
Through the clinical feasibility of our 10-min whole brain T2prep
3D spiral sequence, we were able to apply this technology to a
large cohort of multiple sclerosis patients. Note that although we
chose MWF for this study, any surrogate marker of myelin could
be used with our novel statistical reduction technique, such as
magnetization transfer ratio (Horsfield, 2005) or diffusion MRI
metrics (Rovaris et al., 2005).
We illustrated the use of our whole brain white matter
gamma-mixture fitting on some of the largest MWF quantitative
analyses conducted on multiple sclerosis patients. Another
hurdle when investigating WM damage is localizing abnormal
WM. Semi-automated delineation of WM lesions has been
the gold standard for this purpose although it requires expert
knowledge, is particularly time consuming, and biased in
nature. We proposed an alternative solution by examining
all WM voxels without the use of user-defined lesion masks.
Whole brain approaches have been carried out previously with
histogram analyses, both from MTR and diffusion MRI data
(see for example Van Buchem et al., 1996; Cercignani et al.,
2001, respectively). In the current study we chose a whole
WM approach which, contrarily to the aforementioned studies,
preserves an interpretation of the model parameters in terms of
damaged and NAWM. The visible skewness of the data and the
possible presence of two peaks led to choose between a single
gamma and a gamma mixture, with the latter demonstrated to
provide the best fit in all subjects. The position of the peaks of the
first and second components were shown to relate to the amount
of pathological and NAWM, respectively, as shown by the
significant difference in DICE coefficients. Beyond lesional WM,
the first component is assumed to also include dirty WM with
MWF values lower than the high MWF component. This results
in larger ROI[m1 ] volume compared to lesion masks, and would
explain why the absolute value of Dice(lesion mask, ROI[m1 ]) is
not as high as between Dice(NAWM, ROI[m2 ]): the relatively
limited size |lesion mask| of the lesion volume constrains the Dice
numerator |lesion mask∩ROI[m1 ]|, and thus the Dice coefficient
itself, not to be large. Explicitely and automatically distinguishing
between NAWM, with high MWF, and lesional and dirty WM,
with low MWF, is a strength of the gamma mixture model.
The process of biomarker development requires qualification,
i.e., linking the biomarker to the biological process and
clinical endpoints. This work aimed at qualifying MWF by
demonstrating its relevance to explain some of the variance
in patient cortical thickness and to differentiate between
disease subtypes, namely RRMS and SPMS. Through our

4. DISCUSSION
Progressive disability in MS is related to cortical thinning
(Calabrese et al., 2007; Ceccarelli et al., 2008; Ramasamy
et al., 2009; Roosendaal et al., 2011; Batista et al., 2012)
and thus important insights into MS could be obtained
from understanding the mechanisms driving this cortical
loss. The cause of cortical GM atrophy, and whole brain
GM damage in general, in multiple sclerosis is currently
unclear. Although correlation between WM insult (in terms of
lesion load) and GM atrophy has been shown in a number
of studies, other investigations support other independent
processes, such as inflammation. We hypothesized that these
mechanisms differ according to the stage of the disease,
notably WM pathology which is the focus of the present
study. The statistical analysis undertaken allowed to explore the
differential WM correlates of cortical thinning in RRMS and
SPMS patients while avoiding the bias introduced by lesion
masks.

FIGURE 7 | Regression of cortical thickness from the position of the
gamma mixture second mode m2 in the SPMS group.
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in m1 is assumed to result from focal demyelination, likely
predominantly found within lesions and dirty WM. These results
suggest that a small contribution of secondary degeneration
is related to focal WM myelin injury and other sources not
included in our model such as normal aging and primary disease
related GM pathology (i.e., GM lesions Seewann et al., 2011),
may drive the decrease in cortical thickness. The comparatively
high R2 calculated in the SPMS group with only a predictor
corresponding to NAWM suggests that cortical thinning has little
dependence on focal WM damage (of which m1 is a surrogate
marker). In contrast to RRMS, WM with higher MWF, associated
to m2 and often reprensenting the larger volume of WM, had a
profound effect. It may be related to more diffuse inflammation
at this stage of the disease and consequently to more global
white matter damage (Kutzelnigg et al., 2005). Interestingly, as
in Steenwijk et al. (2014), we did not find any influence of age
on cortical thinning in SPMS patients, which suggests that agerelated neuronal loss is likely outweighed by a shift of NAWM
toward lower MWF, possibly illustrating overwhelming global
white matter damage.

statistical approach, three variables describing the distribution
of each patient’s whole brain MWF (m1 , m2 , λ) were used as
independent variables for the multi-variate analysis. Importantly,
the distributions were created for each individual patient without
a prior classification of the data; specifically we did not identify
lesion or NAWM. This approach removes a potential bias
introduced into lesion identification through manual delineation
or correction if lesion-detection is partly automated. We
compared it with models based on mean lesional and NAWM
calculated from lesion masks, and found the adjusted R2 of
the gamma-mixture models to be higher. This demonstrated
the superiority of our statistical reduction technique despite
bypassing the time-consumming step of expert drawing of lesion
masks. Importantly, the modeled mixture parameters could be
interpreted in terms of the underlying WM aspects. Variation
in its lowest mode m1 corresponds to changes in abnormal
WM, variation in m2 corresponds to changes in NAWM and λ
indicates the proportion of abnormal to NAWM.

4.2. Differential Relationship of Cortical
Thinning between RRMS and SPMS
Groups as Assessed from the Gamma
Mixture Model

4.3. Limitations
The causality relationship between WM demyelination and
cortical thinning is restricted to an assumption in this work, and
a longitudinal study would be required to validate it. Additionally
we investigated global GM atrophy, and did not refine the
analysis in terms of individual GM regions. Both of these
aspects will be tackled in future research using the profilometry
framework we introduced recently in Dayan et al. (2016). It
would be particularly useful for these two aims, as it can identify
WM tract connecting a given pair of GM regions, and assess
how MWF changes with time along these tracts. This approach
would be advantageous not only in diseases involving whole
brain WM, such as in MS, but also in disorders known to affect
markedly specific WM tracts, such as the cerebellar peduncles
in ataxia (Dayan et al., 2017) and the corticospinal tracts in
amyotrophic lateral sclerosis (Turner et al., 2009). It will be
combined with Kuceyeski et al. (2015) to explore the association
between GM/WM damage and clinical scores, which was not
done in this work. Another limitation is the lack of a cohort of
normal controls to further interpret the model parameters. An
effort dedicated to recruiting healthy subjects has been started
to remedy this impediment. Finally, although we circumvented
the creation of lesion masks and its associated bias, part of the
processing pipeline still required some minimal editing of the
border between GM and WM masks which could be affected by
lesions.

The multivariate regression models for RRMS and SPMS
demonstrated that the MWF model parameters (m1 , m2 , λ)
were significant in explaining the variance in cortical thickness,
but formed complementary subsets of predictors depending
on the group at stake: λ and m1 (together with age) were
significant predictors for RRMS patients while only m2 was
a significant predictor for SPMS patients. This suggests that
different processes are ongoing, or similar processes but with
different magnitudes, during these two stages of the disease. The
variables m1 and λ are associated with low MWF, assumed to
represent pathological WM, and the fact we did not find them
to be significant predictors of cortical GM atrophy in the SPMS
group contrarily to the RRMS group is an interesting finding.
This is in line with the recent work of Steenwijk et al. (2014)
and Steenwijk et al. (2015) who similarly reported a differential
relationship of WM damage and cortical loss among RRMS
and SPMS patients. In this study traditional T2 hyperintense
lesion load characterized WM pathology. It was shown to be a
significant predictor of cortical thickness in the RRMS group but
not in the SPMS group, for which no WM correlate of cortical
thinning was found (Steenwijk et al., 2014). The advantage of our
study was the utilization of an MRI metric more specific to myelin
damage, namely MWF, with which we could more accurately
characterize this relationship. It notably led us to find a surrogate
of NAWM, m2 , highly correlated with cortical thinning in the
SPMS group, and provided strong support for the existence of a
differential relationship of cortical thinning between RRMS and
SPMS groups.
The moderate adjusted R2 (R2 = 0.16) obtained for the RRMS
group to explain cortical thickness suggests that an increase of
abnormal WM in terms of relative amount and pathology (as
indicated by λ and m1 , respectively) is associated to cortical
thinning, although in a limited fashion. More precisely, a change
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The relationship between cortical GM loss and WM damage in
MS is important to elucidate. We presented in this work a whole
brain WM model to investigate this relationship at the RRMS
and SPMS stage of the disease avoiding the use of lesion masks
and their associated bias. Our results represent one of the first
quantitative studies characterizing the distribution of whole brain
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WM MWF within a large cohort of MS patients and relating these
measures to cortical atrophy.
Our findings supports the idea that secondary degeneration
could play a role in cortical thinning during the first phase of MS
as a result of focal demyelination, in parallel with other processes
such as GM lesions. We also showed that a different mechanism
affected SPMS patients, where high MWF WM presented a strong
correlation with cortical GM loss, possibly driving this atrophy. A
longitudinal analysis would be required to ascertain that cortical
thinning appears after WM damage.
The data reduction technique presented was shown to unravel
a variety of different relationships between WM and GM while
collapsing the high dimensionality of MWF maps to a few
parameters. As it does not rely on lesion masks, it avoids
the associated experimenter bias and does not suffer from the
potential time-consumming operations required to create such
masks. These are important advantages which should make this
technique suitable for other MS studies.
Our study suggests that MWF, as an indirect biomarker of
myelin, is a promising tool to study the influence of myelin
change on cortical atrophy. The rate of cortical loss has been
suggested to relate to the rate of disease progression and our
results provide further evidence that inducing remyelination
would also function as a neuroprotective therapeutic strategy
(Piaton et al., 2010). Coupled to our gamma distribution model,
this imaging biomarker could help adapt therapeutics according
to the different disease stages. In particular, intervention early

on would ideally prevent conversion to the progressive stage of
the disease. To this aim, future work will include examining the
variability of these results across MWF calculation algorithms
and MRI scanners.
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APPENDIX

and selecting the one with the minimum residual sum of
squares (RSS).
Second, among the best 1-predictor, 2-predictor, ..., Npredictor models, we used 10-fold cross-validation to select the
one with the minimum test-RSS. Briefly, the data is split in
10 subsets (“folds”), and selecting 1-fold in turn, the model
is fitted on the remaining 9 folds before being tested on
the selected fold. The test-RSS is the average RSS obtained
from this iterative procedure on the 10 folds: test-RSS =
mean(test-RSSfold1 , test-RSSfold2 , ...test-RSSfold10 ).

Selection of the Best Multivariate Linear
Regression Model
For each approach and each group of MS patients, we had to
choose the best model with respect to the N predictors available.
This was implemented in two steps.
First, given a group and a number K of predictors, we did
an exhaustive search to choose the best K-predictor model.
This was done by comparing all possible K-predictor models,
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